Distribution of sentinel nodes from parotid tumors-A feasibility study.
neck treatment
occult methastasis
parotid tumors
parotidectomy
sentinel node (SN)
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
29
08
2023
received:
01
06
2023
accepted:
22
09
2023
medline:
23
10
2023
pubmed:
30
9
2023
entrez:
30
9
2023
Statut:
ppublish
Résumé
Optimum management of the N0 neck is unresolved in parotid salivary gland cancer. Sentinel node biopsy (SNB) can reliably detect microscopic lymph node metastasis and its´ clinical use is increasing for head and neck tumors. The object of this study was to establish whether the technique is applicable to detect distribution of sentinel nodes for parotid tumors. Prosepective observational study in 30 patients with benign or low-grade T1-T2N0 malignant tumors in the parotid gland planned for surgical treatment. Distribution of SN was detected with a preoperative ultrasound-guided peritumoral injection with a technetium-99 (Tc-99 m) laballed tracer followed by a SPECT-CT and intraoperative measurement in the neck and parotidal tissue. In patients with cytologically suspected malignant tumor or highly unclerar cytology, SNB was also performed. Sentinel nodes (SNs) were detected in 26/30 cases. Out of these, 7 presented with only one SN, whereas multiple sentinel nodes where detected in 19 cases. No SNs were found in neck level 1. SN was detected in level 5 independent of tumor location within the parotid gland. An intraparotidal distribution of SNs was more frequent in larger tumors. The use of SN-technique in the planning of surgical treatment of parotid tumors seems feasible. It may be of clinical value for patients with parotid cancer to enable a more accurate staging and to detect occult metastasis in the SNs within the parotid as well as in the neck, enabaling the possibility to surgically remove all positive SNs at primary surgery and with reduced surgical morbidity.
Sections du résumé
BACKGROUND
Optimum management of the N0 neck is unresolved in parotid salivary gland cancer. Sentinel node biopsy (SNB) can reliably detect microscopic lymph node metastasis and its´ clinical use is increasing for head and neck tumors. The object of this study was to establish whether the technique is applicable to detect distribution of sentinel nodes for parotid tumors.
MATERIALS AND METHODS
Prosepective observational study in 30 patients with benign or low-grade T1-T2N0 malignant tumors in the parotid gland planned for surgical treatment. Distribution of SN was detected with a preoperative ultrasound-guided peritumoral injection with a technetium-99 (Tc-99 m) laballed tracer followed by a SPECT-CT and intraoperative measurement in the neck and parotidal tissue. In patients with cytologically suspected malignant tumor or highly unclerar cytology, SNB was also performed.
RESULTS
Sentinel nodes (SNs) were detected in 26/30 cases. Out of these, 7 presented with only one SN, whereas multiple sentinel nodes where detected in 19 cases. No SNs were found in neck level 1. SN was detected in level 5 independent of tumor location within the parotid gland. An intraparotidal distribution of SNs was more frequent in larger tumors.
CONCLUSIONS
The use of SN-technique in the planning of surgical treatment of parotid tumors seems feasible. It may be of clinical value for patients with parotid cancer to enable a more accurate staging and to detect occult metastasis in the SNs within the parotid as well as in the neck, enabaling the possibility to surgically remove all positive SNs at primary surgery and with reduced surgical morbidity.
Identifiants
pubmed: 37776164
doi: 10.1002/cam4.6612
pmc: PMC10587971
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19667-19672Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Cancer. 1992 Feb 1;69(3):615-9
pubmed: 1730113
Auris Nasus Larynx. 2016 Aug;43(4):446-50
pubmed: 26656731
Cancer. 1999 May 1;85(9):2057-67
pubmed: 10223248
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3181-3191
pubmed: 33369691
Head Neck. 2014 Nov;36(11):1634-7
pubmed: 24123567
Cytopathology. 2019 Jan;30(1):91-98
pubmed: 30303566
Head Neck Pathol. 2022 Mar;16(1):40-53
pubmed: 35312980
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):643-8
pubmed: 21671057
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):720-3
pubmed: 12874071
AJNR Am J Neuroradiol. 2003 Oct;24(9):1757-64
pubmed: 14561598
Cancer Med. 2023 Oct;12(19):19667-19672
pubmed: 37776164
Eur J Surg Oncol. 2020 Nov;46(11):2029-2034
pubmed: 32576478
Arch Otolaryngol Head Neck Surg. 1993 May;119(5):517-20
pubmed: 8484940
Br J Surg. 2015 May;102(6):646-52
pubmed: 25868072
Acta Otolaryngol. 2010 Feb;130(2):286-92
pubmed: 19544204
Eur J Surg Oncol. 2008 Aug;34(8):932-937
pubmed: 18358679
Otolaryngol Head Neck Surg. 2005 Mar;132(3):387-91
pubmed: 15746848
Eur J Cancer. 2015 Dec;51(18):2777-84
pubmed: 26597442
Clin Nucl Med. 2006 Apr;31(4):203-4
pubmed: 16550012
Sci Rep. 2019 Jun 6;9(1):8339
pubmed: 31171810
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1659-1664
pubmed: 27896425